Finch
Finch is a pharmaceutical company that researches and develops novel microbiome therapies for the treatment of autism spectrum disorder.
Business Model:
Revenue: $1.7M
Employees: 51-200
Industries / Tags:
Detailed Finch Information
Geographic Data
Address: 200 Inner Belt Road
City: Somerville
State: MA
Zip: 02143
Country: US
Financial Info
Stage:
series d
Raised Last:
$90M
Raised Total:$189M
Social
Metrics
3,926,510Website Global Rank
3,089Website Monthly Traffic
Twitter Followers
Description
Finch is a pharmaceutical company that researches and develops novel microbiome therapies for the treatment of autism spectrum disorder.
Contact Phone:
+16172296499
Contact Email:
Finch went public on 3/18/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/18/2021
IPO Valuation:
$801M
Ticker Symbol:
FNCH
IPO Price:
$17/share
Amount Raised:
$128M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 10/2017 | Crestovo |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
